Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board
09 sept. 2019 09h00 HE
|
Endonovo Therapeutics Inc.
LOS ANGELES, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical® therapeutic...
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
30 août 2019 09h00 HE
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical®...
Endonovo Therapeutics Announces Second Quarter Results
13 août 2019 13h39 HE
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the...
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast
22 juil. 2019 12h40 HE
|
Endonovo Therapeutics Inc.
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Endonovo Therapeutics Inc. (OTCQB: ENDV), an innovative biotechnology company and commercial-stage developer of noninvasive...
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board
15 juil. 2019 08h30 HE
|
Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive...
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board
21 juin 2019 09h22 HE
|
Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
13 juin 2019 08h30 HE
|
Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire
29 mai 2019 08h30 HE
|
Endonovo Therapeutics Inc.
NEW YORK, May 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine,...